| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |